You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

FEXOFENADINE HYDROCHLORIDE ALLERGY Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Fexofenadine Hydrochloride Allergy patents expire, and what generic alternatives are available?

Fexofenadine Hydrochloride Allergy is a drug marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Hetero Labs Ltd V, Rising, Sciegen Pharms Inc, Sun Pharm Inds, Teva, Unique, and Wockhardt. and is included in ten NDAs.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE ALLERGY is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and four suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fexofenadine Hydrochloride Allergy

A generic version of FEXOFENADINE HYDROCHLORIDE ALLERGY was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FEXOFENADINE HYDROCHLORIDE ALLERGY?
  • What are the global sales for FEXOFENADINE HYDROCHLORIDE ALLERGY?
  • What is Average Wholesale Price for FEXOFENADINE HYDROCHLORIDE ALLERGY?
Summary for FEXOFENADINE HYDROCHLORIDE ALLERGY
Drug patent expirations by year for FEXOFENADINE HYDROCHLORIDE ALLERGY
Recent Clinical Trials for FEXOFENADINE HYDROCHLORIDE ALLERGY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bristol-Myers SquibbPhase 1
Dhaka Medical CollegePhase 2/Phase 3
Opella Healthcare Group SAS, a Sanofi CompanyPhase 3

See all FEXOFENADINE HYDROCHLORIDE ALLERGY clinical trials

Pharmacology for FEXOFENADINE HYDROCHLORIDE ALLERGY

US Patents and Regulatory Information for FEXOFENADINE HYDROCHLORIDE ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 202039-002 Nov 19, 2014 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 079112-004 Feb 8, 2012 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204097-002 Aug 19, 2016 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076502-008 Apr 12, 2011 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204507-003 Sep 16, 2015 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204097-003 Aug 19, 2016 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 079112-006 Feb 8, 2012 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.